Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

High remission rates for new CLL treatment

Prof John Seymour - Peter MacCallum Cancer Centre, Victoria, Australia
High remission rates for new CLL treatment ( Prof John Seymour - Peter MacCallum Cancer Centre, Victoria, Australia )
9 Sep 2015

CLL from a patient and physician perspective

Dr Brian Koffman MD – Medical Director of the CLL Society
CLL from a patient and physician perspective ( Dr Brian Koffman MD – Medical Director of the CLL Society )
9 Sep 2015

Harmonisation of CLL diagnosis and detection of residual disease monitoring by flow cytometry

Dr Andrew Rawstron - St James Institute of Oncology, Leeds, UK
Harmonisation of CLL diagnosis and detection of residual disease monitoring by flow cytometry ( Dr Andrew Rawstron - St James Institute of Oncology, Leeds, UK )
8 Sep 2015

Results of a new phase Ib trial of voxtalisib in combination with chemoimmunotherapy

Prof Farrukh Awan - Ohio State University, Columbus, USA
Results of a new phase Ib trial of voxtalisib in combination with chemoimmunotherapy ( Prof Farrukh Awan - Ohio State University, Columbus, USA )
8 Sep 2015

Highlights from the iwCLL conference: B-cell receptor Btk, PI3K and multi-molecular BCR inhibitors

Dr Amy Johnson – The Ohio State University, Columbus, USA
Highlights from the iwCLL conference: B-cell receptor Btk, PI3K and multi-molecular BCR inhibitors ( Dr Amy Johnson – The Ohio State University, Columbus, USA )
8 Sep 2015

A laboratory model of the hypoxic tumour microenvironment

Dr Giles Best - Royal North Shore Hospital, Sydney, Australia
A laboratory model of the hypoxic tumour microenvironment ( Dr Giles Best - Royal North Shore Hospital, Sydney, Australia )
8 Sep 2015

Phase II study of idelalisib monotherapy in older CLL patients

Dr Andrew Zelenetz – Memorial Sloan Kettering Cancer Center, New York, USA
Phase II study of idelalisib monotherapy in older CLL patients ( Dr Andrew Zelenetz – Memorial Sloan Kettering Cancer Center, New York, USA )
7 Sep 2015

History of the B-cell in its 50th anniversary year

Prof Max Cooper - Emory University, Atlanta, USA
History of the B-cell in its 50th anniversary year ( Prof Max Cooper - Emory University, Atlanta, USA )
7 Sep 2015

Why doesn’t aspirin protect everyone from colorectal cancer?

Dr Hongmei Nan – Indiana University–Purdue University Indianapolis, Indiana, USA
Why doesn’t aspirin protect everyone from colorectal cancer? ( Dr Hongmei Nan – Indiana University–Purdue University Indianapolis, Indiana, USA )
2 Sep 2015

ecancermedicalscience editor's choice for August 2015

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancermedicalscience editor's choice for August 2015 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
27 Aug 2015

Immune tolerance and the microenvironment in head and neck cancer

Prof Gilberto de Castro - Instituto do Cancer do Estado de Sao Paulo, Sao Paulo, Brazil
Immune tolerance and the microenvironment in head and neck cancer ( Prof Gilberto de Castro - Instituto do Cancer do Estado de Sao Paulo, Sao Paulo, Brazil )
28 Jul 2015

Genetics and epigenetics of lymphocyte development and transformation

Dr Stefano Casola - IFOM University of Milan, Milan, Italy
Genetics and epigenetics of lymphocyte development and transformation ( Dr Stefano Casola - IFOM University of Milan, Milan, Italy )
27 Jul 2015